Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

Long‐term efficacy and safety of tildrakizumab for moderate‐to‐severe psoriasis: pooled analyses of two randomized phase III clinical trials (re SURFACE 1 and re SURFACE 2) through 148 weeks

Kristian Reich, Richard Bruce Warren, Lars Iversen, L. Puig, Ignasi Pau‐Charles, Atsuyuki Igarashi and 8 more

Rank
17 of 1,257
Percentile
top 1.4%
Where
British Journal of Dermatology, 2019
Citations
149

From the 2019 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.